Bibliography
Filters: First Letter Of Keyword is P [Clear All Filters]
Poland - GHO Country statistics. Vol 2014. Geneva: World Health Organisation (WHO); 2014. Abstract
Health technology assessment in Poland and Scotland: comparison of process and decisions. Int J Technol Assess Health Care. 2012;28(1):70-6. Abstract
Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidance. Drug Saf. 2013;36(12):1129-49. Abstract
Population access to new vaccines in European countries. Vaccine. 2013;31(27):2862-7. Abstract
Ethical issues in preparing and publishing systematic reviews. J Evid Based Med. 2011;4(2):130-4.
The CIOMS view on the use of placebo in clinical trials. Sci Eng Ethics. 2004;10(1):23-8. Abstract
International ethical regulations on placebo-use in clinical trials: a comparative analysis. Bioethics. 2008;22(1):64-74. Abstract
Casuistry as bioethical method: an empirical perspective. Soc Sci Med. 2001;53(1):71-81. Abstract
[Experiences with and impact of health technology assessment on the German Standing Committee of physicians and patients]. Z Arztl Fortbild Qualitatssich. 2002;96(2):82-90. Abstract
Why consider patients' preferences? A discourse analysis of clinical practice guideline developers. Med Care. 2009;47(8):908-15. Abstract
American College of Physicians Ethics Manual: sixth edition. Ann Intern Med. 2012;156(1 Pt 2):73-104. Abstract
Health Technology Assessment: managing the introduction and use of medical devices in clinical practice in Italy. Expert Rev Med Devices. 2009;6(3):251-7. Abstract
Systematic collection of patient-reported adverse drug reactions: a path to patient-centred pharmacovigilance. Drug Saf. 2013;36(4):277-8.
Health technology assessment--the role of the pharmaceutical panel. Br J Clin Pharmacol. 1998;45(3):217-20.
Health technology assessment in Australia: challenges ahead. Med J Aust. 2007;187(5):262-4. Abstract
Failure or success of electronic search strategies to identify adverse effects data. J Med Libr Assoc. 2012;100(2):130-4.
Simple search techniques in PubMed are potentially suitable for evaluating the completeness of systematic reviews. J Clin Epidemiol. 2013;66(6):660-5. Abstract
Medicines regulation and health technology assessment. Clin Pharmacol Ther. 2010;87(2):152-4. Abstract
Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies. CMAJ. 2006;174(5):635-41. Abstract
What aspects of the health technology assessment process recommended by international health technology assessment agencies received the most attention in Poland in 2008? Int J Technol Assess Health Care. 2011;27(1):84-94. Abstract
Health economics and health technology assessment: perspectives from Australia and New Zealand. Crit Care Clin. 2012;28(1):125-33, vii. Abstract